Gates Ventures News Today

meritocracy approve of this decisiony ap. a few d just a few days ago, cbs newss ran a poll asking americans about this very issue. ver70% responded that colleges should not be allowed to use race in college admissions. a new york times poll recentlyam found 60% of democrats also oppose race as a factor in admissions. americans across the country have rejected affirmative action at the ballot box, too, evenat the b in blue state calia in the 2020 election. democratic leaders in the sta...

WALTHAM, Mass.--(BUSINESS WIRE)--May 28, 2024--

In a study of cells from nearly 400 amyotrophic lateral sclerosis (ALS) patients, MIT researchers identified genomic regions with chemical modifications linked to disease progression.

Trials for detecting dementia are under way between two research groups.

London: An Indian-origin neurologist is part of a world-class research team in the UK that has been awarded a major grant this week to build on recent

The long-term hope is that more people will be able to access new treatments at an earlier stage.

4.04.2024 - Cambridge researchers are helping lead countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve the UKs shocking diagnosis rate. This is a ground-breaking study, to discover the best blood tests for dementia, not just Alzheimers but any type of dementia and for anyone, whatever their background age and other health problems.

Thousands of people across the UK will be offered a blood test to detect dementia, in a bid to revolutionize the country’s ‘shocking’ diagnosis rate.

<p>The Global Alzheimer’s Platform Foundation<em><sup>®</sup></em>, (GAP) is releasing the first results from the Bio-Hermes-001 Study. This study in over 1000 community-based participants from throughout the US compared the results of blood and digital biomarkers with brain amyloid PET scans or cerebrospinal fluid assays. The study<em> </em>revealed a strong correlation between several blood tests, particularly p-tau 217, with the pres...

The Global Alzheimer's Platform Foundation, (GAP) is releasing the first results from the Bio-Hermes-001 Study.